Prevalence and impact of neuropsychiatric symptoms in normal aging and neurodegenerative syndromes: A population-based study fromLatin America
Date
2023-06-23Author
Rodriguez Salgado, Ana M.
Acosta, Isaac
J. Kim, Dani
Zitser, Jenny
Sosa, Ana Luisa
Acosta, Daisy
Jimenez-Velasquez, Ivonne Z.
Guerra, Mariella
Salas, Aquiles
Valvuerdi, Adolfo
Llibre-Guerra, Juan C.
Jeyachandran, Christine
López Contreras, Ricardo
Hesse, Heike
Tanner, Caroline
Llibre Rodríguez, Juan J.
Prina, Matthew
Llibre-Guerra, Jorge J.
Metadata
Show full item recordAbstract
Neuropsychiatric symptoms (NPSs) are common in neurodegenerative diseases; however, little is known about the prevalence of NPSs in Hispanic populations. Neuropsychiatric symptoms (NPSs) are common in neurodegenerative diseases; however, little is known about the prevalence of NPSs in Hispanic populations. Neuropsychiatric symptoms (NPSs) are common in neurodegenerative diseases; however, little is known about the prevalence of NPSs in Hispanic populations. Clinicians involved in the care of elderly populations should proactively screen for NPSs, especially in patients with Parkinsonism, dementia, and PPD, and develop intervention plans to support families and caregivers. Neuropsychiatric symptoms (NPSs) are highly prevalent in Hispanic populations with neurodegenerative diseases. In healthy Hispanic populations, NPSs are predominantly mild and not clinically significant. The most common NPSs include depression, sleep disorders, irritability, and agitation. NPSs explain a substantial proportion of the variance in global caregiver burden.
Collections
The following license files are associated with this item: